- Home
- MAZE vs OBE Comparison
MAZE vs OBE Comparison
Compare MAZE & OBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAZE
- OBE
- Stock Information
- Founded
- MAZE 2018
- OBE 1979
- Country
- MAZE United States
- OBE Canada
- Employees
- MAZE N/A
- OBE N/A
- Industry
- MAZE
- OBE Oil & Gas Production
- Sector
- MAZE
- OBE Energy
- Exchange
- MAZE NYSE
- OBE Nasdaq
- Market Cap
- MAZE 367.0M
- OBE 409.0M
- IPO Year
- MAZE 2025
- OBE N/A
- Fundamental
- Price
- MAZE $16.93
- OBE $5.51
- Analyst Decision
- MAZE Strong Buy
- OBE Buy
- Analyst Count
- MAZE 4
- OBE 2
- Target Price
- MAZE $23.50
- OBE $11.50
- AVG Volume (30 Days)
- MAZE 129.8K
- OBE 370.8K
- Earning Date
- MAZE 08-14-2025
- OBE 08-13-2025
- Dividend Yield
- MAZE N/A
- OBE N/A
- EPS Growth
- MAZE N/A
- OBE N/A
- EPS
- MAZE 0.34
- OBE N/A
- Revenue
- MAZE $167,500,000.00
- OBE $525,689,636.00
- Revenue This Year
- MAZE N/A
- OBE N/A
- Revenue Next Year
- MAZE N/A
- OBE $8.69
- P/E Ratio
- MAZE $53.00
- OBE N/A
- Revenue Growth
- MAZE N/A
- OBE 15.98
- 52 Week Low
- MAZE $6.71
- OBE $3.88
- 52 Week High
- MAZE $18.50
- OBE $7.53
- Technical
- Relative Strength Index (RSI)
- MAZE N/A
- OBE 49.95
- Support Level
- MAZE N/A
- OBE $5.27
- Resistance Level
- MAZE N/A
- OBE $6.11
- Average True Range (ATR)
- MAZE 0.00
- OBE 0.22
- MACD
- MAZE 0.00
- OBE -0.06
- Stochastic Oscillator
- MAZE 0.00
- OBE 30.56
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.